ARCB — ARCBEST CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ARCB?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their ARCB position last quarter, 2 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +2 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin)
- +2 tracked investors reported holding ARCB at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About ARCBEST CORP (ARCB)
ARCBEST CORP (ARCB) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $31M. Across recent filings, tracked investors recorded 7 new positions, 8 increased, 4 reduced, and 6 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ARCB
How many top investors track ARCB
Only 2 tracked investors report this position.
ARCB Ownership Composition
How ARCBEST CORP is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ARCB
2 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares101KValue$14.5M% Portfolio0.00%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares142.3KValue$20.4M% Portfolio0.01%
Previously held ARCB
These investors reported ARCB in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 4K | $282.3K | Mar 31, 2025 |
| Ray Dalio | Bridgewater Associates | 4.2K | $298.6K | Mar 31, 2025 |
Recent activity
- Reduced$3.6M(-85.75%)Nov 14, 2024
- Increased$3.8M(22.05%)Feb 14, 2025
- Reduced$304K(-89.29%)May 15, 2025
- Increased$7.5M(2165.75%)Aug 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- $1.4MMay 15, 2026
- Increased$20.4M(888.26%)Aug 14, 2026
- Reduced$19.7M(-37.11%)Nov 14, 2024
- Increased$11.3M(46.77%)May 15, 2025
- Increased$20M(61.83%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Increased$14.5M(320.84%)Aug 14, 2026
- New$992.8KAug 14, 2024
- Sold$0(-100.00%)Nov 13, 2024
- New$228.5KFeb 13, 2025
- Increased$298.6K(72.72%)May 14, 2025
- Sold$0(-100.00%)Aug 13, 2025
- Reduced$1.3M(-71.27%)Aug 14, 2024
- Increased$4.8M(270.91%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $282.3KMay 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
- New$30.9MAug 14, 2024
- $19.8MMay 15, 2024
- $5.9MMay 15, 2024
Frequently asked questions
- How many institutional investors hold ARCB?
- 2 tracked institutional investors disclosed a position in ARCB (ARCBEST CORP) in their most recent 13F filing.
- Who is the largest institutional holder of ARCB?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ARCB, valued at $31M.
- Did institutional ownership of ARCB increase or decrease?
- Across recent 13F filings, tracked investors recorded 7 new positions, 8 increased, 4 reduced, and 6 fully exited ARCB.
- Where does this ARCB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.